CUE
Cue Biopharma, Inc.
+1.55 (+4.55%)35.73USD50.8K成交股數260M市值–本益比(近四季)6.9股價營收比+166.7%營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 11 · 2.0M · 3 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 2.0M |
| 近 180 天 淨額 | −2.0M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | 08-17 | Ray Sumita | Chief Legal Compliance Officer | S 公開市場賣出 | 6.4K | 30.35 | 196K | 119K | SEC |
| 2026-08-13 | 08-17 | Ray Sumita | Chief Legal Compliance Officer | S 公開市場賣出 | 4 | 31.13 | 124.52 | 119K | SEC |
| 2026-08-13 | 08-17 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | M 選擇權執行 | 13.6K | – | – | 54.6K | SEC |
| 2026-08-13 | 08-17 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | S 公開市場賣出 | 1.5K | 29.37 | 45K | 53.1K | SEC |
| 2026-08-13 | 08-17 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | S 公開市場賣出 | 4.1K | 30.35 | 125K | 49.0K | SEC |
| 2026-08-13 | 08-17 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | S 公開市場賣出 | 3 | 31.13 | 93.39 | 49.0K | SEC |
| 2026-08-13 | 08-17 | Ray Sumita | Chief Legal Compliance Officer | M 選擇權執行 | 18.2K | – | – | 127K | SEC |
| 2026-08-13 | 08-17 | Ray Sumita | Chief Legal Compliance Officer | S 公開市場賣出 | 2.4K | 29.37 | 70K | 125K | SEC |
| 2026-08-13 | 08-14 | Lin Shao-Lee | Chief Executive Officer | S 公開市場賣出 | 2.4K | 28.11 | 67K | 716K | SEC |
| 2026-08-13 | 08-14 | Lin Shao-Lee | Chief Executive Officer | S 公開市場賣出 | 5.4K | 27.19 | 147K | 719K | SEC |
| 2026-08-13 | 08-14 | Lin Shao-Lee | Chief Executive Officer | S 公開市場賣出 | 10.5K | 29.48 | 308K | 706K | SEC |
| 2026-08-12 | 08-14 | Lin Shao-Lee | Chief Executive Officer | S 公開市場賣出 | 34.2K | 26.99 | 924K | 730K | SEC |
| 2026-08-12 | 08-14 | Lin Shao-Lee | Chief Executive Officer | S 公開市場賣出 | 5.8K | 27.75 | 160K | 724K | SEC |
| 2026-08-12 | 08-14 | Lin Shao-Lee | Chief Executive Officer | M 選擇權執行 | 109K | – | – | 764K | SEC |
| 2026-07-30 | 08-03 | Ahlers James M | Chief Financial Officer | A 獲配股票 | 25.5K | – | – | 25.5K | SEC |
| 2026-07-13 | 07-15 | Borie Dominique Christian | Chief Medical Officer | A 獲配股票 | 31.5K | – | – | 31.5K | SEC |
| 2026-07-09 | 08-28 | Sarraf Pasha | Director | A 獲配股票 | 18.4K | – | – | 29.2K | SEC |
| 2026-07-09 | 08-28 | Garzone Pamela | Director | A 獲配股票 | 18.9K | – | – | 18.9K | SEC |
| 2026-07-09 | 07-10 | Camardo Daniel A. | Director | A 獲配股票 | 21.8K | – | – | 21.8K | SEC |
| 2026-07-09 | 07-10 | Garzone Pamela | Director | A 獲配股票 | 21.8K | – | – | 21.8K | SEC |
| 2026-07-09 | 07-10 | Lin Shao-Lee | Chief Executive Officer | A 獲配股票 | 328K | – | – | 655K | SEC |
| 2026-07-09 | 07-10 | Meehan Viola Mong | Director | A 獲配股票 | 21.8K | – | – | 21.8K | SEC |
| 2026-07-09 | 07-10 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | A 獲配股票 | 40.9K | – | – | 40.9K | SEC |
| 2026-07-09 | 07-10 | Ray Sumita | Chief Legal Compliance Officer | A 獲配股票 | 54.6K | – | – | 109K | SEC |
| 2026-07-09 | 07-10 | Sarraf Pasha | Director | A 獲配股票 | 21.8K | – | – | 32.6K | SEC |
| 2026-05-03 | 05-07 | Lin Shao-Lee | CHIEF EXECUTIVE OFFICER | A 獲配股票 | 328K | – | – | 328K | SEC |
| 2025-12-30 | 01-02 | Sarraf Pasha | Director | P 公開市場買進 | 4.2K | 0.31 | 1K | 4.2K | SEC |
| 2025-12-30 | 01-02 | Sarraf Pasha | Director | P 公開市場買進 | 77.1K | 0.30 | 23K | 81.4K | SEC |
| 2025-12-30 | 01-02 | Sarraf Pasha | Director | P 公開市場買進 | 86.9K | 0.32 | 28K | 168K | SEC |
| 2025-12-30 | 01-02 | Sarraf Pasha | Director | P 公開市場買進 | 78.1K | 0.31 | 24K | 246K | SEC |
| 2025-12-30 | 01-02 | Sarraf Pasha | Director | P 公開市場買進 | 77.4K | 0.30 | 23K | 324K | SEC |
| 2024-12-16 | 12-18 | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 30.0K | 1.03 | 31K | 165K | SEC |
| 2023-08-25 | 08-29 | Suri Anish | PRESIDENT AND CSO | P 公開市場買進 | 4.0K | 2.76 | 11K | 136K | SEC |
| 2023-08-14 | 08-16 | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 3.0K | 2.86 | 9K | 135K | SEC |
| 2023-03-23 | 03-27 | Kiener Peter A | Director | M 選擇權執行 | 9.7K | 2.86 | 28K | 9.7K | SEC |
| 2023-03-23 | 03-27 | Kiener Peter A | Director | S 公開市場賣出 | 9.3K | 3.28 | 31K | 357 | SEC |
| 2022-08-22 | 08-23 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | F 繳稅扣股 | 2.8K | 3.05 | 9K | 14.3K | SEC |
| 2022-08-21 | 08-23 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 6.7K | – | – | 17.1K | SEC |
| 2022-06-14 | 06-16 | Gray Cameron | Director | F 繳稅扣股 | 51.6K | 3.20 | 165K | 687K | SEC |
| 2022-06-14 | 06-16 | Gray Cameron | Director | X 選擇權履約 | 61.1K | 2.70 | 165K | 739K | SEC |
| 2022-05-27 | 05-31 | Morich Frank | Director | P 公開市場買進 | 28.0K | 3.75 | 105K | 28.0K | SEC |
| 2022-05-24 | 05-25 | Fletcher Aaron G.L. | Director | P 公開市場買進 | 55.0K | 3.34 | 184K | 940K | SEC |
| 2022-05-23 | 05-25 | Fletcher Aaron G.L. | Director | P 公開市場買進 | 150K | 3.52 | 528K | 885K | SEC |
| 2022-03-31 | 04-04 | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | G 贈與 | 10.0K | – | – | 132K | SEC |
| 2022-03-31 | 04-04 | Fletcher Aaron G.L. | Director | P 公開市場買進 | 735K | 4.76 | 3.5M | 735K | SEC |
| 2022-03-31 | 04-04 | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | M 選擇權執行 | 75.0K | – | – | 174K | SEC |
| 2022-03-31 | 04-04 | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 32.1K | 4.88 | 157K | 142K | SEC |
| 2022-03-31 | 04-04 | Suri Anish | PRESIDENT AND CSO | M 選擇權執行 | 16.7K | – | – | 111K | SEC |
| 2022-03-31 | 04-04 | Suri Anish | PRESIDENT AND CSO | F 繳稅扣股 | 7.1K | 4.88 | 34K | 104K | SEC |
| 2021-11-16 | 11-17 | Kiener Peter A | Director | M 選擇權執行 | 1.4K | 2.86 | 4K | 1.4K | SEC |
| 2021-11-16 | 11-17 | Kiener Peter A | Director | S 公開市場賣出 | 1.4K | 18.02 | 25K | 0 | SEC |
| 2021-11-15 | 11-17 | Suri Anish | President and CSO | M 選擇權執行 | 8.0K | 8.26 | 66K | 102K | SEC |
| 2021-11-15 | 11-17 | Suri Anish | President and CSO | S 公開市場賣出 | 8.0K | 18.05 | 144K | 94.0K | SEC |
| 2021-11-15 | 11-17 | Kiener Peter A | Director | M 選擇權執行 | 18.8K | 2.86 | 54K | 18.8K | SEC |
| 2021-11-15 | 11-17 | Kiener Peter A | Director | S 公開市場賣出 | 18.8K | 17.92 | 337K | 0 | SEC |
| 2021-11-11 | 11-15 | Suri Anish | President and CSO | S 公開市場賣出 | 20.0K | 15.07 | 301K | 94.0K | SEC |
| 2021-11-11 | 11-15 | Suri Anish | President and CSO | M 選擇權執行 | 20.0K | 6.42 | 128K | 114K | SEC |
| 2021-10-06 | 10-08 | Suri Anish | PRESIDENT AND CSO | F 繳稅扣股 | 14.1K | 12.97 | 183K | 94.0K | SEC |
| 2021-10-03 | 10-08 | Suri Anish | PRESIDENT AND CSO | M 選擇權執行 | 33.3K | – | – | 108K | SEC |
| 2021-10-01 | 10-05 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 1.3K | 7.50 | 9K | 11.7K | SEC |
| 2021-10-01 | 10-05 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 1.3K | 14.21 | 18K | 10.5K | SEC |
| 2021-09-30 | 10-08 | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | F 繳稅扣股 | 31.7K | 14.57 | 462K | 98.7K | SEC |
| 2021-09-30 | 10-08 | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | M 選擇權執行 | 75.0K | – | – | 130K | SEC |
| 2021-09-24 | 09-27 | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | P 公開市場買進 | 3.4K | 14.72 | 50K | 55.4K | SEC |
| 2021-09-23 | 09-27 | Suri Anish | PRESIDENT AND CSO | M 選擇權執行 | 20.0K | 6.42 | 128K | 94.8K | SEC |
| 2021-09-23 | 09-27 | Suri Anish | PRESIDENT AND CSO | S 公開市場賣出 | 20.0K | 15.23 | 305K | 74.8K | SEC |
| 2021-08-23 | 10-05 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | M 選擇權執行 | 6.7K | – | – | 12.4K | SEC |
| 2021-08-23 | 10-05 | Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | F 繳稅扣股 | 2.0K | – | – | 10.5K | SEC |
| 2021-03-16 | 03-17 | Pienta Kenneth | Chief Medical Officer | S 公開市場賣出 | 439 | 15.09 | 7K | 2.0K | SEC |
| 2021-03-16 | 03-17 | Pienta Kenneth | Chief Medical Officer | M 選擇權執行 | 439 | 5.00 | 2K | 2.4K | SEC |
| 2021-03-15 | 03-17 | Pienta Kenneth | Chief Medical Officer | M 選擇權執行 | 13.0K | 5.00 | 65K | 15.0K | SEC |
| 2021-03-15 | 03-17 | Pienta Kenneth | Chief Medical Officer | S 公開市場賣出 | 13.0K | 15.10 | 196K | 2.0K | SEC |
| 2021-02-17 | 02-18 | Pienta Kenneth | Chief Medical Officer | M 選擇權執行 | 1.3K | 2.86 | 4K | 3.3K | SEC |
| 2021-02-17 | 02-18 | Pienta Kenneth | Chief Medical Officer | S 公開市場賣出 | 4.3K | 15.06 | 64K | 2.0K | SEC |
| 2021-02-17 | 02-18 | Pienta Kenneth | Chief Medical Officer | M 選擇權執行 | 3.0K | 5.00 | 15K | 6.3K | SEC |
| 2021-02-16 | 02-18 | Pienta Kenneth | Chief Medical Officer | M 選擇權執行 | 16.0K | 2.86 | 46K | 18.0K | SEC |
| 2021-02-16 | 02-18 | Pienta Kenneth | Chief Medical Officer | S 公開市場賣出 | 16.0K | 15.15 | 242K | 2.0K | SEC |
| 2021-01-20 | 02-18 | Pienta Kenneth | Chief Medical Officer | S 公開市場賣出 | 2.7K | 15.07 | 41K | 2.0K | SEC |
| 2021-01-20 | 02-18 | Pienta Kenneth | Chief Medical Officer | M 選擇權執行 | 2.7K | 2.86 | 8K | 4.7K | SEC |
| 2021-01-20 | 01-22 | Pienta Kenneth | Chief Medical Officer | P 公開市場買進 | 2.7K | 15.07 | 41K | 4.7K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Bleichroeder LP | 371K | 11.7M | 新進 | 新進 |
| Driehaus Capital Management LLC | 292K | 9.2M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 162K | 5.1M | 新進 | 新進 |
| Ikarian Capital, LLC | 104K | 3.3M | 新進 | 新進 |
| Tetragon Partners GP Ltd | 93.8K | 3.0M | 新進 | 新進 |
| STEMPOINT CAPITAL LP | 67.0K | 2.1M | 新進 | 新進 |
| BlackRock, Inc. | 57.8K | 1.8M | 新進 | 新進 |
| ADAR1 Capital Management, LLC | 55.2K | 1.7M | 新進 | 新進 |
| Lion Point Capital, LP | 52.9K | 1.7M | 新進 | 新進 |
| Squadron Capital Management LLC | 50.0K | 1.6M | 新進 | 新進 |
| DIADEMA PARTNERS LP | 48.4K | 1.5M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 47.8K | 1.5M | 新進 | 新進 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31.5K | 993K | 新進 | 新進 |
| UBS Group AG | 26.7K | 843K | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 25.6K | 809K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 24.5K | 772K | 新進 | 新進 |
| Texas Capital Bank Wealth Management Services Inc | 22.9K | 722K | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 14.7K | 464K | 新進 | 新進 |
| Persistent Asset Partners Ltd | 12.3K | 389K | 新進 | 新進 |
| Robertson Stephens Wealth Management, LLC | 11.1K | 351K | 新進 | 新進 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11.0K | 347K | 新進 | 新進 |
| Seven Fleet Capital Management LP | 10.7K | 338K | 新進 | 新進 |
| NORTHERN TRUST CORP | 9.1K | 288K | 新進 | 新進 |
| ADVISORY RESEARCH INC | 8.6K | 271K | 新進 | 新進 |
| STIFEL FINANCIAL CORP | 8.2K | 259K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 49 +47 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 49 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 1.6M · 22.6% |
| 合計季末市值 | 51.8M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 318K |
|---|---|
| 與上期比 | -2.8% |
| 佔流通股數 | 4.38% |
| 日均成交量 | 181K |
| 回補天數 | 1.8 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 318K | -2.8% | 4.38% | 181K | 1.8 |
| 2026-08-14 | 327K | -6.4% | 4.51% | 201K | 1.6 |
| 2026-07-31 | 350K | +13.6% | 4.82% | 185K | 1.9 |
| 2026-07-15 | 308K | +3.3% | 4.24% | 139K | 2.2 |
| 2026-06-30 | 298K | +8.4% | 4.10% | 111K | 2.7 |
| 2026-06-15 | 275K | -1.0% | 3.79% | 73.7K | 3.7 |
| 2026-05-29 | 278K | +8.8% | 3.82% | 107K | 2.6 |
| 2026-05-15 | 255K | -11.7% | 3.51% | 2.0M | 1.0 |
| 2026-04-30 | 289K | -96.2% | 3.98% | 534K | 1.0 |
| 2026-04-15 | 7.5M | +183.1% | 103.82% | 44.9M | 1.0 |
| 2026-03-31 | 2.7M | +17.2% | 36.68% | 3.4M | 1.0 |
| 2026-03-13 | 2.3M | +27.6% | 31.28% | 1.1M | 2.1 |
| 2026-02-27 | 1.8M | -10.0% | 24.52% | 293K | 6.1 |
| 2026-02-13 | 2.0M | -8.6% | 27.24% | 439K | 4.5 |
| 2026-01-30 | 2.2M | +16.8% | 29.81% | 2.1M | 1.1 |
| 2026-01-15 | 1.9M | +28.6% | 25.51% | 1.8M | 1.0 |
| 2025-12-31 | 1.4M | +290.6% | 19.83% | 2.2M | 1.0 |
| 2025-12-15 | 369K | -16.5% | 5.08% | 312K | 1.2 |
| 2025-11-28 | 442K | -13.3% | 6.08% | 182K | 2.4 |
| 2025-11-14 | 510K | +39.6% | 7.02% | 569K | 1.0 |
| 2025-10-31 | 365K | +6.1% | 5.03% | 186K | 2.0 |
| 2025-10-15 | 344K | -44.6% | 4.74% | 362K | 1.0 |
| 2025-09-30 | 621K | -6.8% | 8.55% | 173K | 3.6 |
| 2025-09-15 | 666K | -25.9% | 9.17% | 129K | 5.2 |
| 2025-08-29 | 898K | -6.1% | 12.36% | 127K | 7.1 |
| 2025-08-15 | 957K | +10.8% | 13.17% | 122K | 7.9 |